Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients
Authors:
- Marina PittoMPMarina Pitto
- Francesca RaimondoFRFrancesca Raimondo
- Chiara ZoiaCZChiara Zoia
- Laura BrighinaLBLaura Brighina
- Carlo FerrareseCFCarlo Ferrarese
- Massimo MasseriniMMMassimo Masserini
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in Neurobiology of Aging
- Vol. 26 (6) , 833-838
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Up-regulation of Glycohydrolases in Alzheimer's Disease Fibroblasts Correlates with Ras ActivationJournal of Biological Chemistry, 2003
- Presenilin-1, Nicastrin, Amyloid Precursor Protein, and γ-Secretase Activity Are Co-localized in the Lysosomal MembraneJournal of Biological Chemistry, 2003
- Biological markers in Alzheimer diseaseNeurobiology of Aging, 2003
- Differential regulation of adenylyl cyclase in fibroblasts from sporadic and familial Alzheimerʼs disease cases with PS1 and APP mutationsNeuroReport, 1997
- Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal systemNeuron, 1995
- Elevated Levels of the Endosomal‐Lysosomal Proteinase Cathepsin D in Cerebrospinal Fluid in Alzheimer DiseaseJournal of Neurochemistry, 1995
- Cortical distribution of gangliosides in Alzheimer's diseaseNeurochemistry International, 1992
- Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosisJournal of Inherited Metabolic Disease, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A new procedure for the extraction, purification and fractionation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973